Loading...
Loading...
Arena Pharmaceuticals Inc
ARNA dipped 44.12% to $2.09 in the pre-market session. Analysts at Piper Jaffray downgrade ARNA from "overweight" to "neutral."
Orexigen Therapeutics Inc
OREX lost 9.01% to $6.16 in the pre-market session. OREX shares have fallen 26.65% over the past 52-weeks, while the S&P500 index has gained 5.55% in the same period.
Acorn Energy Inc
ACFN fell 6.58% to $4.40 in the pre-market session. ACFN shares have fallen 15.44% over the past 52-weeks, while the S&P500 index has gained 5.55% in the same period.
VIVUS Inc
VVUS slipped 5.59% to $5.91 in the pre-market trading. VVUS' shares have fallen 40.78%over the past 52-weeks, while the S&P500 index has gained 5.55% in the same period.
Read more
from Benzinga's Markets.© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: NewsShort IdeasPre-Market OutlookIntraday UpdateMarketsTrading IdeasBenzinga’s Top Pre-Market NASDAQ LosersBiotechnologyHealth CareInformation TechnologyIT Consulting & Other ServicesPharmaceuticals
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in